Overall health quality of life (QOL) indicators may capture non-urological issues such as back pain or arthritis when used as patient reported outcomes measures (PROM) for urethral stricture surgery. We hypothesize that generic health QOL indicators are not meaningful in the assessment of urethral stricture surgery and should be replaced with stricture-specific measures.
INTRODUCTION AND OBJECTIVES:
Overall health quality of life (QOL) indicators may capture non-urological issues such as back pain or arthritis when used as patient reported outcomes measures (PROM) for urethral stricture surgery. We hypothesize that generic health QOL indicators are not meaningful in the assessment of urethral stricture surgery and should be replaced with stricture-specific measures.
METHODS: Patient data was obtained from the Trauma and Urologic Reconstructive Network of Surgeons (TURNS) collaborative database. Patients who underwent a successful urethroplasty, defined by passage of a cystoscope through the repair and no secondary procedure on post-operative evaluation, were included in this study. All patients completed pre-and post-operative questionnaires based on a recently published urethral stricture surgery questionnaire validated in 2013.
RESULTS: Inclusion criteria were met by 201 patients who underwent successful urethroplasty at a mean age of 47 years. Postoperative questionnaires were completed at a mean time of 7.3 months after surgery. Urethral-stricture specific measures improved after surgery: mean LUTS score (13.1 to 4.0, p<0.05), Peelings voiding picture (3.1 to 1.7, p<0.05), and overall interference of urinary symptoms on life (3.0 to 1.6, p<0.05). Mean overall health status visual analog scale (74.2 to 80.0, p<0.05) and EQ-5D index scores (0.90 to 0.95, p<0.05) also improved; however, individual EQ-5D measures assessing mobility, self-care, and activity level did not change. Although individual EQ-5D measures for pain/discomfort (1.48 to 1.23, p<0.05) and anxiety/depression (1.33 to 1.21, p<0.05) improved, these measures did not correlate with a successful urethroplasty to the same extent as stricture-specific measures ( Figure) . Only 2 of the 11 patients who reported worse overall pain/discomfort also reported worse bladder or urethral/penile pain when asked about urological-specific pain.
CONCLUSIONS: Generic health QOL indicators may capture medical issues not related to stricture disease and should be replaced with urethral stricture-specific outcomes measures. As PROMs become more prevalent and utilized to evaluate surgeon outcomes and determine reimbursements, it is important to ensure that appropriate condition-specific measures are assessed.
Source of Funding: None

MP36-15 LIVE SURGERY IN UROLOGY -EVALUATION OF THE EDUCATIONAL BENEFIT OF THE INTERNATIONAL MEETING ON RECONSTRUCTIVE UROLOGY (IMORU)
Victor Schuettfort*, Jesssica Langetepe, Roland Dahlem, Christoph-Philip Reiss, Clemens Rosenbaum, Tim Ludwig, Felix Chun, Margit Fisch, Luis Kluth, Hamburg, Germany INTRODUCTION AND OBJECTIVES: There is an ongoing debate about the benefits and safety of live surgery; however, only few data is available. The International Meeting on Reconstructive Urology (IMORU) is a meeting of live and semi live reconstructive surgeries (e.g., urethroplasty, fistula repair, and implantation of artificial urinary sphincter and penile prostheses), performed by high-volume surgeons only. The aim of this study was to evaluate the participants 0 educational benefit including assessment of the quality of surgeries at the 2016 IMORU (VII).
METHODS: At the IMORU VII, all visitors were invited to complete a standardized non-validated survey at each day of surgery. Visitors were able to evaluate the educational benefit and the Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e471 quality of the surgeries using a Likert rating scale from excellent to bad (1-5). RESULTS: Participants 0 survey showed that overall the surgeons (1.34, n¼22.9), the surgical technique (1.48 n¼17.6) and the surgical presentation (1.55, n¼19.8) were perceived as excellent. The structural quality of the meeting was found to be very high (faculty: 1.35, n¼24; program: 1.38, n¼24; presentation: 1.55, n¼23.6; poster sessions: 1.82, n¼21.67; technique: 1.4, n¼23,34). Improvement of knowledge (1.8, n¼24.3) and surgical armamentarium (2.06, n¼23.7) were both rated good, suggesting that most participants value the educational benefit. Eighty seven percent of participants would attend the meeting again.
CONCLUSIONS: We demonstrated a high educational/learning benefit for visitors participating at a live and semi-live surgery meeting. Standardized participant surveys may be helpful to compare surgical outcomes and educational benefits of live and semi-live surgery meetings. METHODS: We identified all patients (n¼101) from two institutions who failed urethroplasty and underwent salvage DVIU. Triamcinolone (400mg) was injected intra-spongiosal in 86 patients at the time of the DVIU. The primary outcome of stricture recurrence was defined as need for an additional urethral procedure and inability to pass a 16 French flexible cystoscope. Baseline demographic and stricture characteristics for those with and without recurrence were compared using t-test, Chi square, and MannWhitney test where applicable. Univariable and multivariable logistic regression was performed to identify factors associated with salvage DVIU failure.
RESULTS: Median age at DVIU among all patients (n¼101) was 45.0 years (interquartile range [IQR] 35-57). Pre-urethroplasty stricture location was bulbar (n¼82, 81.1%), bulbo-membranous (n¼11, 10.9%), penile (n¼5, 5.0%), and panurethral (n¼3, 3.0%). Recurrent stricture length was 1.1 cm (mean). DVIU success rate was 68.3% with median follow-up of 44.5 months (IQR 21-75). Median maximum flow rate and International Prostate Symptom Score (IPSS) before and 6 months after DVIU was 7 vs 12 cc/s and 10 vs 6, respectively. Diabetes, smoking, age or initial stricture location had no association with salvage DVIU success. Patients with DVIU failure were less likely to have received triamcinolone vs. those without recurrence (75.0% vs 89.9%, p¼0.05). On multivariable analysis, triamcinolone trended towards protection against recurrence, with an odds ratio [OR] 0.34, p¼0.08. Patients without recurrence showed a trend towards greater improvement in IPSS at 6 months (-5 versus -1, p¼0.88).
CONCLUSIONS: Conclusions: Salvage DVIU of short recurrent strictures after urethroplasty is moderately effective. Baseline demographic and stricture characteristics are poor predictors of success, while triamcinolone injection may add efficacy to DVIU.
Source of Funding: None
MP36-17 THE T-PLASTY AS A MODIFIED YV-PLASTY FOR THE TREATMENT OF HIGHLY RECURRENT BLADDER NECK STENOSIS: HIGH SUCCESS AND PATIENT'S SATISFACTION RATES
Clemens Rosenbaum*, Philipp Reiss, Oliver Engel, Luis Kluth, Margit Fisch, Roland Dahlem, Hamburg, Germany INTRODUCTION AND OBJECTIVES: Highly recurrent bladder neck stenosis (BNS) after surgery for benign prostatic hyperplasia (BPH) is a rare but troublesome problem. After multiple endoscopic treatment attempts, open surgery can be the last therapeutic option before urinary diversion. We present the extended follow-up of outcome and patient's satisfaction of the previously described T-plasty: A modified YV-plasty of the bladder neck in patients with highly recurrent BNS.
METHODS: In all, 30 patients who underwent T-plasty between December 2008 and July 2016 were retrospectively identified from our prospective urethroplasty data base. Patients were interviewed by telephone. Primary end point of was the treatment specific success rate defined as bladder neck patency without any history of recurrent stenosis or need of further intervention. Secondary endpoint was patient related outcome measurement.
RESULTS: Mean age was 68.3 yrs. (range 47-86), mean follow up was 44.9 months (range 2-92). As initial surgery for BPH, 83.3% of patients (n¼25) had a TURP, 10% had a HoLEP (n¼3) and 6.7% had a Greenlight-Laser (n¼2). Mean number of prior transurethral procedures to treat the BNS was 4.6 (range 1-19). Preoperatively mean Qmax was 6.8 ml/sec, mean post void residual volume was 141ml. Mean time of surgery was 111 min. (range 74-175). There was no relevant blood loss. No postoperative complications higher grad II according to Clavien-Dindo occurred. Mean time of hospital stay was 13.2 days (range 8-21). Success rate was 100%, one patient needed a permanent catheter due to acontractile detrusor. In one patient, preexisting stress incontinence increased. No de-novo stress incontinence occurred. In no patient further endoscopic or surgical treatment was needed. Postoperatively mean Qmax was 19.8 ml/sec, mean post void residual volume was 37ml. Both values were significantly improved compared to preoperative measurements (p¼0.019 and p¼0.01). In all 87.5% of patients were (very) satisfied. Only one patient was dissatisfied. In this patient preexisting stress incontinence increased postoperatively. Number of prior therapies did not correlate with patient's satisfaction.
CONCLUSIONS: The T-plasty represents a successful and safe procedure to treat highly recurrent BNS after surgery for BPH.
